Etoposide-induced apoptosis in lymphoblastoid leukaemic MOLT-4 cells: Evidence that chromatin condensation, loss of phosphatidylserine asymmetry and apoptotic body formation can occur independently

Apoptosis

Volumn 7, Issue 1, 2002, Pages 59-68

  Ramirez, C D ^a   Catchpoole, D R ^b  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Apoptosis; Apoptotic bodies; Etoposide; Leukaemia; Phosphatidylserine

Indexed keywords

AURINTRICARBOXYLIC ACID; ETOPOSIDE; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CELL SURFACE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOBLASTOID CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; STAINING;

APOPTOSIS; CELL MEMBRANE; CELL NUCLEUS; CHROMATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FLOW CYTOMETRY; HUMANS; MICROSCOPY, ELECTRON; PHOSPHATIDYLSERINES; TUMOR CELLS, CULTURED;

EID: 0036172570     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013564928999     Document Type: Article

References (60)

1. Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics
2. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
3. Phagocytic clearance of apoptotic cells: Food for thought
4. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis
5. Multiple pathways for apoptotic nuclear fragmentation
6. Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation
7. The actin-myosin cytoskeleton mediates reversible agonist-induced membrane blebbing
8. Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes
9. Protease inhibitors block apoptosis at intermediate stages: A compared analysis of DNA fragmentation and apoptotic nuclear morphology
10. The role of DNA fragmentation in apoptosis
11. Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA stability to denaturation
12. Degradation of apoptotic cells and fragments in HL-60 suspension cultures after induction of apoptosis by camptothecin and ethanol
13. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
14. The apoptosis-necrosis paradox Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
15. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sentitive activities
16. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine
17. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
18. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
19. Phosphatidylserine plasma membrane asymmetry in vivo: A pancellular phenomenon which alters during apoptosis
20. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
21. A receptor for phosphatidylserine-specific clearance of apoptotic cells
22. Measurement of membrane phospholipid asymmetry in normal and sickle cell erythrocytes by means of annexin V binding
23. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
24. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis
25. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity
26. Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis: Role of apoptosis blebs in monocyte chemotaxis
27. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: Delayed loss of membrane permeability rather than DNA fragmentation as an indicator programmed cell death
28. Formation of apoptotic bodies is associated with internucleosomal DNA fragmentation during drug-induced apoptosis
29. Aurintricarboxyic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: Correlation with suppression of endonuclease activity
30. Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation
31. Calcium-activated DNA fragmentation kills immature thymocytes
32. Activation-induced cell death in T cell hybridomas is due to apoptosis
33. Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells
34. Aurintricarboxylic acid is a nonspecific enzyme inhibitor
35. Inhibition of topoisomerase II by aurintricarboxylic acid: Implications for mechanism of apoptosis
36. Aurin tricarboxyic acid, the anti-AIDS compound, prevents the binding of interferon-α to its receptor
37. Aurintricarboxylic acid is a potent inhibitor of phosphofructokinase
38. Rosette-forming human lymphoid cell lines I establishment and evidence for origin of thymus-derived lymphocytes
39. Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells
40. Plasma membrane alterations and cytoskeletal changes in apoptosis
41. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
42. 2/M arrest: Higher order DNA fragmentation as an indicator of mechanism
43. The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in Molt-4 cells without concomitant DNA fragmentation
44. Actin is cleaved during constitutive apoptosis
45. Down-regulation of actin genes precedes microfilament network disruption and actin cleavage during p53-mediated apoptosis
46. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
47. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis
48. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2
49. Recognition and phogocytosis of apoptotic cells
50. Phagocytic docking without shocking
51. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin
52. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis
53. Apoptosis: The importance of being eaten
54. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis
55. 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response
56. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis
57. 3)
58. Human CD14 mediates recognition and phagocytosis of apoptotic cells
59. Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from carbohydrate-binding site
60. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine